Genetics of Huntington Disease

References

1. 1.↵
   1. Bates GP

   . History of genetic disease: the molecular genetics of Huntington disease: a history. Nat Rev Genet 2005;6:766–73

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Ross CA,
   2. Tabrizi SJ

   . Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011;10:83–98

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Myers RH

   . Huntington's disease genetics. NeuroRx 2004;1:255–62

   Abstract/FREE Full Text
4. 4.↵
   1. Borrell-Pagès M,
   2. Zala D,
   3. Humbert S,
   4. et al

   . Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 2006;63:2642–60

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Walker FO

   . Huntington's disease. Lancet 2007;369:218–28

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Koutsis G,
   2. Karadima G,
   3. Kladi A,
   4. et al

   . The challenge of juvenile Huntington disease: to test or not to test. Neurology 2013;80:990–96

   CrossRef
7. 7.↵
   1. Trottier Y,
   2. Devys D,
   3. Imbert G,
   4. et al

   . Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 1995;10:104–10

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Bates G

   . Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003;361:1642–44

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Semaka A,
   2. Creighton S,
   3. Warby S,
   4. et al

   . Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 2006;70:283–94

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Tabrizi SJ,
    2. Langbehn DR,
    3. Leavitt BR,
    4. et al

    . Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791–801

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Klöppel S,
    2. Henley SM,
    3. Hobbs NZ,
    4. et al

    . Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience 2009;164:205–19

    CrossRefPubMed
12. 12.↵
    1. Shin H,
    2. Kim MH,
    3. Lee SJ,
    4. et al

    . Decreased metabolism in the cerebral cortex in early-stage Huntington's disease: a possible biomarker of disease progression? J Clin Neurol 2013;9:21–25

    CrossRefPubMed
13. 13.↵
    1. Versluis MJ,
    2. van der Grond J,
    3. van Buchem MA,
    4. et al

    . High-field imaging of neurodegenerative diseases. Neuroimaging Clin N Am 2012;22:159–71, ix

    CrossRefPubMed
14. 14.↵
    1. Bohanna I,
    2. Georgiou-Karistianis N,
    3. Sritharan A,
    4. et al

    . Diffusion tensor imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits. Brain Imaging Behav 2011;5:171–80

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Rosas HD,
    2. Tuch DS,
    3. Hevelone ND,
    4. et al

    . Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 2006;21:1317–25

    CrossRefPubMedWeb of Science